BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

543500

EVOQ

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Evoq Remedies Limited Share Price Update

As of the latest trading session, Evoq Remedies Limited share price is currently at ₹ 3.25, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 3.25 and ₹ 3.25. Over the past year, Evoq Remedies Limited has achieved a return of -68.32 %. In the last month alone, the return has been 26.95 %. Read More...

Evoq Remedies Limited fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    8.10

  • P/E Ratio (TTM)

    81.25

  • Beta

    0.48

  • Book Value / share

    17.88

  • Return on equity

    1.80%

  • EPS (TTM)

    0.04

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Evoq Remedies Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 11.76
Operating Expense 14.04
Net Profit 0.09
Net Profit Margin (%) 0.76
Earnings Per Share (EPS) 0.04
EBITDA 0.18
Effective Tax Rate (%) 30.76
Particulars MAR 2024 (Values in Cr)
Revenue 4.05
Operating Expense 5.70
Net Profit 0.45
Net Profit Margin (%) 11.11
Earnings Per Share (EPS) 0.33
EBITDA 0.62
Effective Tax Rate (%) 26.22
Particulars MAR 2023 (Values in Cr)
Revenue 20.39
Operating Expense 24.13
Net Profit 1.62
Net Profit Margin (%) 7.94
Earnings Per Share (EPS) 1.19
EBITDA 2.28
Effective Tax Rate (%) 29.38
Particulars MAR 2022 (Values in Cr)
Revenue 16.78
Operating Expense 15.32
Net Profit 1.09
Net Profit Margin (%) 6.49
Earnings Per Share (EPS) 0.70
EBITDA 1.46
Effective Tax Rate (%) 25.34
Particulars MAR 2021 (Values in Cr)
Revenue 10.02
Operating Expense 9.07
Net Profit 0.72
Net Profit Margin (%) 7.18
Earnings Per Share (EPS) 71.55
EBITDA 0.95
Effective Tax Rate (%) 25.26
Particulars MAR 2024 (Values in Cr)
Book Value / Share 18.56
ROE % 1.80
ROCE % 1.91
Total Debt to Total Equity 0.28
EBITDA Margin 15.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 18.22
ROE % 6.76
ROCE % 6.97
Total Debt to Total Equity 0.37
EBITDA Margin 11.23
Particulars MAR 2022 (Values in Cr)
Book Value / Share 17.03
ROE % 9.12
ROCE % 9.11
Total Debt to Total Equity 0.34
EBITDA Margin 8.70
Particulars MAR 2021 (Values in Cr)
Book Value / Share 743.02
ROE % 189.47
ROCE % 249.35
Total Debt to Total Equity 0.01
EBITDA Margin 9.48
Particulars MAR 2020 (Values in Cr)
Book Value / Share 22.60
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.25
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 36.86
Total Liabilities 36.86
Total Equity 25.23
Share Outstanding 13600000
Price to Book Ratio 0.47
Return on Assets (%) 1.22
Return on Capital (%) 1.53
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.15
Total Assets 34.89
Total Liabilities 34.89
Total Equity 24.78
Share Outstanding 13600000
Price to Book Ratio 0.71
Return on Assets (%) 4.64
Return on Capital (%) 4.71
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.09
Total Assets 33.33
Total Liabilities 33.33
Total Equity 23.16
Share Outstanding 13600000
Price to Book Ratio 1.33
Return on Assets (%) 3.27
Return on Capital (%) 3.48
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 8.04
Total Liabilities 8.04
Total Equity 0.74
Share Outstanding 10000
Price to Book Ratio 0.00
Return on Assets (%) 8.89
Return on Capital (%) 96.13
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 5.65
Total Liabilities 5.65
Total Equity 0.02
Share Outstanding 10000
Price to Book Ratio 0.00
Return on Assets (%) 0.00
Return on Capital (%) 1.05
Particulars MAR 2024 (Values in Cr)
Net Income 0.61
Cash from Operations 5.47
Cash from Investing -0.01
Cash from Financing -5.33
Net change in Cash -0.03
Free Cash Flow 5.49
Particulars MAR 2023 (Values in Cr)
Net Income 2.28
Cash from Operations -3.67
Cash from Investing -0.01
Cash from Financing 1.41
Net change in Cash -2.94
Free Cash Flow -3.66
Particulars MAR 2022 (Values in Cr)
Net Income 1.45
Cash from Operations -26.05
Cash from Investing 0.00
Cash from Financing 29.49
Net change in Cash 3.06
Free Cash Flow -26.05
Particulars MAR 2021 (Values in Cr)
Net Income 0.71
Cash from Operations 0.03
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.03
Free Cash Flow 0.03
Particulars MAR 2020 (Values in Cr)
Net Income 0.00
Cash from Operations -0.02
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash -0.01
Free Cash Flow -0.02
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 790.90 48.02 6.73 27760.59 574.70 / 1035.70
KOTHARI INDUSTRIAL CORPORATION 276.45 49.63 18.29 2147.57 3.82 / 276.45
MYSORE PETRO CHEMICALS LTD. 122.85 6.28 0.35 80.88 117.45 / 261.90
OSWAL AGRO MILLS LTD 84.43 22.28 1.34 1133.30 41.50 / 108.00
STANDARD INDUSTRIES LTD. 20.27 144.79 1.00 130.39 17.50 / 38.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 790.90 64.67 11.07 27760.59 574.70 / 1035.70
UTIQUE ENTERPRISES LIMITED 4.66 18.64 0.35 25.94 3.77 / 10.88
COMPUTER POINT LTD. 5.08 0.00 0.45 15.24 4.24 / 11.63
KOTHARI INDUSTRIAL CORPORATION 276.45 49.63 18.31 2147.57 3.82 / 276.45

Evoq Remedies Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
3.25 1.88 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 3.10
  • 26 Days 3.10
  • 10 Days 3.00
  • 50 Days 3.80
  • 12 Days 3.00
  • 100 Days 5.10
  • 20 Days 3.00
  • 200 Days 6.90
3.25 PIVOT

First Support

3.25

First Resistance

3.25

Second Support

3.25

Second Resistance

3.25

Third Support

3.25

Third Resistance

3.25

RSI

55.83

ADX

22.16

MACD

-0.09

Williams % R

0.00

Commodity Channel Index (CCI)

154.58

Date

2025-04-28

Week

32000.00

Same Day

16000.00

Month

31250.00

1 Year

0.48

3 Year

0.66

Over 1 Month

26.95%

down

Over 1 Year

-68.32%

down

Over 3 Months

-52.27%

down

Over 3 Years

-40.00%

down

Over 6 Months

-56.66%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

Evoq Remedies Limited shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
88.78%
Promoter Holdings
11.21%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Dhruv Ganji 2825000.0 (11.35%) Public Shareholding
Prashant Sevantikar 2825000.0 (11.35%) Public Shareholding
Patel Payal Bhumishth 1500071.0 (6.02%) Shareholding of Promoter and Promoter Group
Bhumishth Narendrabhai Patel 1291574.0 (5.19%) Shareholding of Promoter and Promoter Group
Anand Mohan . 380000.0 (1.53%) Public Shareholding
Auxilia Pharmaceuticals Private Limited 71.0 (0.0%) Shareholding of Promoter and Promoter Group
Dahyabhai Mafatlal Patel 71.0 (0.0%) Shareholding of Promoter and Promoter Group
Sushilabahen Narendrakumar Patel 71.0 (0.0%) Shareholding of Promoter and Promoter Group
Narendrakumar Gangaramdas Patel 71.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

Evoq Remedies Limited corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Evoq Remedies Limited Share Price

Evoq Remedies Limited was originally incorporated as 'Salus Life Science and Research Private Limited' at Ahmedabad, Gujarat on February 24th, 2010 vide Certificate of Incorporation issued by Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, name of the Company was changed to 'Evoq Remedies Private Limited' on July 15th, 2019 with Certificate of Incorporation pursuant to change of name issued by Registrar of Companies, Ahmedabad. Consequent upon the conversion of Company into Public Limited Company, the name was changed to 'Evoq Remedies Limited' and fresh Certificate of Incorporation dated July 28th, 2021 was issued by Registrar of Companies, Ahmedabad.

Although Company was formed in year 2010, it started operations in year 2018 onwards. The Company is a recognized trading house of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs at affordable price catering to customers located in Ahmedabad. The company procures the pharmaceuticals Raw Materials products and chemicals from the customers who are having WHO-GMP approved production facilities in India and by focusing on its distribution skills. The Company is engaged in pharmaceutical business involving marketing, trading and distribution of pharmaceutical formulation products such as antibiotic drugs, antimalarial drugs, antiallergic & anti cold drugs, analgesic/ antipyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections.

The Company offer wide range of pharmaceuticals formulation products, of which around 120 products are marketed by them under their own brand name, the manufacturing of which is outsourced by them to third parties. Apart from pharmaceutical formulation products, we also deal in trading of active pharmaceutical ingredients (API's).

In areas like Pharmaceuticals Raw Materials, Excipients, Bulk Drugs etc., Company specializes in offering quality products and affordable trading in Gujarat. In the healthcare segment, the Company being into trading business, hence offers a wide basket of products. These pharmaceutical raw materials include both active pharmaceutical ingredients (APIs) and inactive ingredients or excipients.

The Company made a public issue of 36,00,000 Equity Shares by raising funds aggregating to Rs. 9.72 Crore in March, 2022.

Parent organization Indian Private
NSE symbol [-]
Founded 2010
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Evoq Remedies Ltd?

Answer Field

The share price of Evoq Remedies Ltd for NSE is ₹ 0.00 and for BSE is ₹ 3.25.

What is the Market Cap of Evoq Remedies Ltd?

Answer Field

The market cap of Evoq Remedies Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 8.10 Cr. as of now.

What is the 52 Week High and Low of Evoq Remedies Ltd?

Answer Field

The 52 Week High and Low of Evoq Remedies Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 12.28 and ₹ 2.11.

How to Buy Evoq Remedies Ltd share?

Answer Field

You can trade in Evoq Remedies Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Evoq Remedies Ltd?

Answer Field

The 1 year returns on the stock has been -68.32%.

What is the Current Share Price of Evoq Remedies Ltd?

Answer Field

Evoq Remedies Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 3.25 as on Apr 28 2025 12:00 AM.

What is the Market Cap of Evoq Remedies Ltd Share?

Answer Field

The market cap of Evoq Remedies Ltd for NSE ₹ 0.0 & for BSE ₹ 8.10 as on Apr 28 2025 12:00 AM.

What is the P/E Ratio of Evoq Remedies Ltd Share?

Answer Field

As on Apr 28 2025 12:00 AM the price-to-earnings (PE) ratio for Evoq Remedies Ltd share is 81.25.

What is the PB ratio of Evoq Remedies Ltd Share?

Answer Field

As on Apr 28 2025 12:00 AM, the price-to-book (PB) ratio for Evoq Remedies Ltd share is 17.88.

How to Buy Evoq Remedies Ltd Share?

Answer Field

You can trade in Evoq Remedies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Evoq Remedies Ltd Share on Bajaj Broking App?

Answer Field

To buy Evoq Remedies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Evoq Remedies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|